Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jingyin Qinghua Fang
- Development stage
- Unknown
- Lead developer
- Shuguang Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Jingyin Qinghua Fang is a traditional Chinese medicine (TCM) herbal formula developed and used for the treatment of mild COVID-19. It is administered as a decoction or granule, following TCM principles, and is based on classical herbal combinations. The formula has been studied in clinical trials for its efficacy in alleviating symptoms such as fever, sore throat, and cough in patients with mild COVID-19[1][9]. While the precise mechanism of action has not been fully elucidated for this specific formula, similar TCM formulas have demonstrated antiviral effects by modulating immune responses and potentially interfering with viral entry into host cells through mechanisms such as downregulation of ACE2 receptor expression and inhibition of TMPRSS2 activity. The developer and lead sponsor for clinical studies involving Jingyin Qinghua Fang is Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine[1][9].
- Brand names
- Jingyin Qinghua Fang
- Other names
- Jingyin Qinghua Fang
Beyond the preview
Go deeper on Jingyin Qinghua Fang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jingyin Qinghua Fang.